$CMLF News
Last published 4y ago
- 4y agoCMLFSMFRSMFRWSema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business HighlightsGlobeNewswire37% increase in fourth quarter test volumes (excluding COVID-19 tests) compared to the same period last year Record quarterly test volume of nearly 83,000 24% growth in fourth quarter revenue (excluding COVID-19 tests) compared to the same period l
- 5y agoCMLFMGTATWSTSema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform CompanyGlobeNewswireSema4 Holdings Corp ("Sema4") to debut on Nasdaq as a publicly traded company dedicated to transforming healthcare by applying artificial intelligence and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic mode
- 5y agoCMLFMGTANVTAOMIC+2Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of DirectorsBusiness WireSema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of renowned executive Jason Ryan to its Board of Directors. Mr. Ryan will begin serving on Sema4's B
- 5y agoCMLFCM Life Sciences and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Business CombinationBusiness WireCM Life Sciences (NASDAQ:CMLF), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, has filed its definitive proxy statement with the Securities and Exchange Commission (the "SEC") in
- 5y agoCMLFSema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data OfficerBusiness WireSema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of Andrew Kasarskis, PhD, to the newly established role of Chief Data Officer (CDO). Dr. Kasarskis b
- 5y agoCMLFSema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy StatementBusiness WireUpdated statement includes Q1 2021 financial results Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, and CM Life Sciences (NASDAQ:CMLF), a special purpose acquisition company, o
- 5y agoCMLFAdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and OutcomesBusiness WireExpanding their investment in precision medicine, AdventHealth is leveraging Sema4's health intelligence platform to enable a range of clinical and research initiatives AdventHealth and Sema4, a patient-centered health intelligence company leveraging
- 5y agoCMLFSema4 to Participate in Upcoming Investor ConferencesBusiness WireSema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced that members of the Sema4 management team will participate in fireside chats at two upcoming virtual investor confer
- 5y agoCMLFSema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed MergerBusiness WireSema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, and CM Life Sciences (NASDAQ:CMLF), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC a
- 5y agoCMLFCM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statements in Accordance with Recent SEC GuidanceBusiness WireCM Life Sciences and merger partner Sema4 remain committed to closing transaction as soon as practicable and expect to file proxy statement in next several days CM Life Sciences, Inc. (NASDAQ:CMLF) today announced that it has filed with the Securiti
- 5y agoCMLFNorthShore and Sema4 Launch System-Wide Genomics Program to Improve Primary and Specialty Care with Data-Driven InsightsBusiness WireOrganizations commit to expanding the impact of genomics and advanced health intelligence among diverse populations to address disparities in personalized health NorthShore University HealthSystem (NorthShore) and Sema4, a patient-centered health in
- 5y agoSYNCNEBCFRXCMLFMoore Kuehn Encourages SYNC, NEBC, FRX, and CMLF Investors to Contact Law FirmPR NewswireMoore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
- 5y agoCMLFSema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate GrowthBusiness WireNEW YORK & STAMFORD, Conn.--(BUSINESS WIRE)--Sema4, an AI- and machine learning-driven patient-centered genomic and clinical data intelligence company, and CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, today announced they have entered into a definitive business combination agreement. Upon c ...